A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance
Public ClinicalTrials.gov record NCT02799745. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance (ENACT)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study was to compare the time to prostate cancer progression (pathological or therapeutic progression) between patients treated with enzalutamide versus patients undergoing active surveillance.
Study identification
- NCT ID
- NCT02799745
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 227 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 9, 2016 (Actual)
- Primary completion
- Aug 28, 2020 (Actual)
- Completion
- Aug 28, 2020 (Actual)
- Last update posted
- Dec 6, 2024
2016 – 2020
United States locations
- U.S. sites
- 50
- U.S. states
- 25
- U.S. cities
- 44
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site US10034 | Birmingham | Alabama | 35223 | — |
| Site US10024 | Homewood | Alabama | 35209 | — |
| Site US10007 | Tucson | Arizona | 85704 | — |
| Site US10055 | Tucson | Arizona | 85741 | — |
| Site US10004 | Los Angeles | California | 90048 | — |
| Site US10026 | Sacramento | California | 95670 | — |
| Site US10010 | San Diego | California | 92123 | — |
| Site US10051 | Aurora | Colorado | 80045 | — |
| Site US10029 | Denver | Colorado | 80211 | — |
| Site US10054 | Denver | Colorado | 80220 | — |
| Site US10072 | Bradenton | Florida | 34205 | — |
| Site US10057 | Lakeland | Florida | 33805 | — |
| Site US10038 | Chicago | Illinois | 60611 | — |
| Site US10062 | Chicago | Illinois | 60612 | — |
| Site US10074 | Chicago | Illinois | 60612 | — |
| Site US10018 | Glenview | Illinois | 60026 | — |
| Site US10071 | Lake Barrington | Illinois | 60010 | — |
| Site US10046 | Carmel | Indiana | 46033 | — |
| Site US10009 | Jeffersonville | Indiana | 47130 | — |
| Site US10037 | New Orleans | Louisiana | 70112 | — |
| Site US10006 | Shreveport | Louisiana | 71106 | — |
| Site US10001 | Towson | Maryland | 21204 | — |
| Site US10032 | Boston | Massachusetts | 02111 | — |
| Site US10008 | Troy | Michigan | 48084 | — |
| Site US10069 | Lincoln | Nebraska | 68516 | — |
| Site US10044 | Omaha | Nebraska | 68114 | — |
| Site US10067 | Omaha | Nebraska | 68130 | — |
| Site US10061 | Lebanon | New Hampshire | 03756 | — |
| Site US10049 | Morristown | New Jersey | 07962 | — |
| Site US10043 | Voorhees Township | New Jersey | 08043 | — |
| Site US10068 | Brooklyn | New York | 11215 | — |
| Site US10050 | Cheektowaga | New York | 14225 | — |
| Site US10030 | Garden City | New York | 11530 | — |
| Site US10028 | Poughkeepsie | New York | 12601 | — |
| Site US10021 | Syracuse | New York | 13210 | — |
| Site US10022 | Syracuse | New York | 13210 | — |
| Site US10047 | Gastonia | North Carolina | 28053 | — |
| Site US10045 | Cleveland | Ohio | 44195 | — |
| Site US10015 | Middleburg Heights | Ohio | 44130 | — |
| Site US10053 | Oklahoma City | Oklahoma | 73104 | — |
| Site US10063 | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Site US10052 | Lancaster | Pennsylvania | 17604 | — |
| Site US10014 | Warwick | Rhode Island | 02886 | — |
| Site US10019 | Myrtle Beach | South Carolina | 29572 | — |
| Site US10011 | Nashville | Tennessee | 37209 | — |
| Site US10056 | Dallas | Texas | 75231 | — |
| Site US10036 | Houston | Texas | 77027 | — |
| Site US10035 | San Antonio | Texas | 78229 | — |
| Site US10058 | Richmond | Virginia | 23235 | — |
| Site US10017 | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02799745, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 6, 2024 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02799745 live on ClinicalTrials.gov.